PH11300A - Oxaprostaglandins - Google Patents

Oxaprostaglandins

Info

Publication number
PH11300A
PH11300A PH14690A PH14690A PH11300A PH 11300 A PH11300 A PH 11300A PH 14690 A PH14690 A PH 14690A PH 14690 A PH14690 A PH 14690A PH 11300 A PH11300 A PH 11300A
Authority
PH
Philippines
Prior art keywords
oxaprostaglandins
Prior art date
Application number
PH14690A
Other languages
English (en)
Inventor
M Johnson
H Hess
G Ferry
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/355,644 external-priority patent/US4094899A/en
Application filed by Pfizer filed Critical Pfizer
Publication of PH11300A publication Critical patent/PH11300A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
PH14690A 1972-06-02 1973-06-04 Oxaprostaglandins PH11300A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25921572A 1972-06-02 1972-06-02
US05/355,644 US4094899A (en) 1972-06-02 1973-04-30 Oxaprostaglandins

Publications (1)

Publication Number Publication Date
PH11300A true PH11300A (en) 1977-11-02

Family

ID=26947161

Family Applications (3)

Application Number Title Priority Date Filing Date
PH14690A PH11300A (en) 1972-06-02 1973-06-04 Oxaprostaglandins
PH17029A PH11931A (en) 1972-06-02 1975-04-07 Lower alkyl ketophosphonates
PH17030A PH12035A (en) 1972-06-02 1975-04-07 Oxaprostaglandin intermediate

Family Applications After (2)

Application Number Title Priority Date Filing Date
PH17029A PH11931A (en) 1972-06-02 1975-04-07 Lower alkyl ketophosphonates
PH17030A PH12035A (en) 1972-06-02 1975-04-07 Oxaprostaglandin intermediate

Country Status (19)

Country Link
JP (3) JPS5314062B2 (ja)
AR (2) AR199300A1 (ja)
CA (1) CA1095034A (ja)
CH (3) CH590224A5 (ja)
DD (2) DD124594A5 (ja)
DE (2) DE2327813A1 (ja)
DK (1) DK143498C (ja)
ES (2) ES441003A1 (ja)
FI (1) FI55995C (ja)
GB (3) GB1440603A (ja)
IE (1) IE38568B1 (ja)
IL (2) IL50311A (ja)
IN (1) IN138739B (ja)
LU (1) LU67738A1 (ja)
NL (1) NL162902C (ja)
NO (1) NO145438C (ja)
PH (3) PH11300A (ja)
SE (4) SE415756B (ja)
YU (1) YU36497B (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES416865A1 (es) * 1972-07-13 1976-03-01 Pfizer Procedimiento para preparar w-pentanorprostaglandinas sus- tituidas en la posicion 15.
WO2021040628A1 (en) 2019-08-28 2021-03-04 Igloocompany Pte. Ltd. System and method for controlling multiple locks

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3538120A (en) * 1967-05-22 1970-11-03 Ciba Geigy Corp Cyclopentyl-alkanoic acids
ZA721159B (en) * 1971-03-22 1972-12-27 Ici Ltd Process for the separation of the c-15 epimers of 20-ethyl-9a,11alpha,15-trihydroxy-5-cis-13-trans-prostadienoic acid

Also Published As

Publication number Publication date
JPS4954349A (ja) 1974-05-27
SE7608223L (sv) 1976-07-19
AU5639373A (en) 1974-12-05
DE2344838B2 (de) 1981-04-09
IL50311A (en) 1977-08-31
GB1440603A (en) 1976-06-23
NL162902C (nl) 1980-07-15
IL42373A (en) 1977-08-31
PH11931A (en) 1978-09-13
NL7307740A (ja) 1973-12-04
SE418857B (sv) 1981-06-29
DD109859A5 (ja) 1974-11-20
CA1095034A (en) 1981-02-03
JPS5314062B2 (ja) 1978-05-15
NO145438B (no) 1981-12-14
SE7608222L (sv) 1976-07-19
IN138739B (ja) 1976-03-27
PH12035A (en) 1978-10-16
GB1440602A (en) 1976-06-23
CH586716A5 (ja) 1977-04-15
FI55995B (fi) 1979-07-31
YU146973A (en) 1982-02-25
DE2344838A1 (de) 1973-12-20
DE2344839A1 (de) 1974-02-28
YU36497B (en) 1984-02-29
JPS5239629A (en) 1977-03-28
DK143498B (da) 1981-08-31
LU67738A1 (ja) 1973-12-10
ES441003A1 (es) 1977-03-16
DE2344838C3 (de) 1982-03-18
NO145438C (no) 1982-03-24
DK143498C (da) 1982-01-11
AR203386A1 (es) 1975-09-08
IE38568B1 (en) 1978-04-12
NL162902B (nl) 1980-02-15
NO740849L (no) 1973-12-04
IL42373A0 (en) 1973-07-30
DE2344839B2 (de) 1976-06-24
CH589074A5 (ja) 1977-06-30
DD124594A5 (ja) 1977-03-02
FI55995C (fi) 1979-11-12
AR199300A1 (es) 1974-08-23
SE7608221L (sv) 1976-07-19
SE415756B (sv) 1980-10-27
CH590224A5 (ja) 1977-07-29
JPS5231054A (en) 1977-03-09
DE2327813A1 (de) 1973-12-20
GB1440601A (en) 1976-06-23
ES441002A1 (es) 1977-03-01
IE38568L (en) 1973-12-02
JPS5728706B2 (ja) 1982-06-18

Similar Documents

Publication Publication Date Title
CS609973A2 (en) Nosic informace
CS283873A2 (en) Zpusob rafinace tavenin zeleznych kovu
GB1405253A (en) 1- 2-substituted-chromonyloxy-w-hydroxy-3-phenoxy-propanes
AU6329873A (en) Flameprofing
GB1407713A (en) 2-alkoxy-cephalosporins
AU6362373A (en) N-propargylacetanilide herbicedes
AU5993373A (en) N-sulphenylated carbamidoximes
GB1401579A (en) Indolo-quinolizines
GB1402226A (en) 3-cyanochromones
GB1408010A (en) Sulphamoylphenyl-imidazolidinones
HK45678A (en) Imino-isoindolinones
AU6332973A (en) Bulbholders
GB1401735A (en) Imino-lactams
AU5191873A (en) Benzylpyrimidines
AU5983773A (en) Alkylsulphonyl-2-trifluoromethyl-benzimidazoles
GB1405254A (en) Bis- substituted-henoxy- propanes
GB1400667A (en) 4-spirocyclopropyl-androstenes
HK10479A (en) Weatherbar
GB1415691A (en) Bracks
GB1402045A (en) 11-o-methanesulphonylerythromycins
AU5900173A (en) Thiazolopyrimidines
GB1406396A (en) Mould-vibrating arragnements
PH11300A (en) Oxaprostaglandins
GB1400604A (en) 2-acyl-5-nitrothiazoles
GB1404276A (en) 15-oxygenated-17a-unsubstituted-d-homosteroids